virion – Page 4 – Communicable Diseases Research

Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2

SARS-CoV-2에 의한 인간 배아 줄기 세포 감염의 증거

Article

Published on 2022-06-102022-09-11
Journal: Frontiers in Cellular and Infection Microbiology
[Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료기술, 치료법, 치료제,

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer

SARS-CoV-2의 N-말단 도메인을 표적으로 하는 항체는 스파이크 삼량체를 파괴합니다

Article

Published on 2022-06-012022-09-12
Journal: The Journal of Clinical Investigation
[Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] acute respiratory syndrome Adaptive immunity antibody Antigen B cell binding Cell cell-to-cell spread Cluster coronavirus COVID-19 Culture disrupt dominant epitope functional Genetic human Angiotensin-converting enzyme human antibody response IGHV1-24 immunoglobulins immunology inhibited mice MOST N-terminal domain neutralizing antibody NTD Protective Protective antibody Protein provide receptor recognize representing S protein SARS-CoV-2 SARS-CoV-2-neutralizing antibody Sequencing single B cell specificity spike trimer the receptor-binding domain the S protein the SARS-CoV-2 trimer Trimers virion Virology Virology. virus
[DOI] 10.1172/JCI159062 PMC 바로가기 [Article Type] Article

Stillbirth due to SARS-CoV-2 placentitis without evidence of intrauterine transmission to fetus: association with maternal risk factors

태아에 대한 자궁내 전파의 증거가 없는 SARS-CoV-2 태반염으로 인한 사산: 산모 위험 인자와의 연관성

Multicenter Study

Published on 2022-06-012022-09-11
Journal: Ultrasound in obstetrics & gynecology : the offici
[Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 affected affecting Analysis asphyctic association Asymptomatic Autopsy carried caused Chain Reaction characterized Clinical characteristics Combination coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis death demise diagnosed electron microscopy Evidence evidence of examined Factor Factors fetal fetal death fetal infection fetus FGR Greece Gross growth Gynecology histological histological change histopathological identify immunostaining independent Infection Inflammatory intervillous space intrauterine fetal death lesion less live birth Microscopy mild clinical symptom mild clinical symptoms molecular mother multicenter Multiple multiple sclerosis Neonates no evidence of obstetrics occurred organs pathology Placenta placental Placentas placentitis polymerase chain polymerase chain reaction positive potential risk predisposing factors pregnancies Pregnancy pregnant women prenatally ranged Regression regression analysis respiratory retrieved risk risk factor Risk factors SARS-CoV-2 SARS-CoV-2 placentitis SARS-CoV-2 spike protein Seven severe acute respiratory syndrome Coronavirus Society Spike protein Stillbirth stillborn Thrombophilia thrombophilia. tissues Transmission Ultrasound Viral Viral transmission virion virions was performed was used
[DOI] 10.1002/uog.24906 PMC 바로가기 [Article Type] Multicenter Study

Development of an integrated environmental monitoring protocol for SARS-CoV-2 contamination. Applications at the IRCSS San Martino Polyclinic Hospital in Genoa, Italy

SARS-CoV-2 오염에 대한 통합 환경 모니터링 프로토콜 개발. 이탈리아 제노바에 있는 IRCSS San Martino Polyclinic Hospital의 애플리케이션

Article

Published on 2022-06-012022-09-11
Journal: Environmental research
[Category] COVID19(2023년), SARS, 치료기술,

Platelet and extracellular vesicles in COVID-19 infection and its vaccines

Review article

Published on 2022-06-012022-10-05
Journal: Transfusion and apheresis science : official journ
[Category] COVID19(2023년), SARS, 바이오마커,

SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5

SARS-CoV-2 ORF7a는 숙주 인자 SERINC5의 항바이러스 효과를 강력하게 억제합니다

Article

Published on 2022-05-262022-09-11
Journal: Nature Communications
[Category] COVID19(2023년), SARS, 치료제,

Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target

잠재적 치료 표적으로서 SARS-COV-2 막 단백질 (M)과 증식 세포 핵 항원 (PCNA) 사이의 상호 작용의 특성화

Article

Published on 2022-05-232022-08-31
Journal: Frontiers in Cellular and Infection Microbiology
[Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘,

Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes

중증 급성 호흡기 증후군 코로나바이러스 2 바이러스혈증은 코로나바이러스 질병 2019 심각도와 연관되어 있으며 임상 결과를 예측합니다

Observational Study

Published on 2022-05-032022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat
[Category] COVID19(2023년), MERS, SARS, 바이오마커, 임상, 진단, 치료기술,

[키워드] 19 outcome 2 RNAemia 2 viremia acute respiratory syndrome acute respiratory syndrome coronavirus Admission Antibody titers bloodstream Care clinical clinical outcomes Cohort coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 CoV COVID COVID-19 COVID-19 patient COVID-19 severity cross-sectional discharge disease severity electron tomography hazard ratio Health Organization Hospitalized Host immune response host immune responses ICU ICU Patients immune responses immunostaining indicate Inflammatory biomarker Inpatients Level Mortality Neutralizing antibody titer neutralizing antibody titers non-ICU outcome outcomes Outpatient outpatients Patient pellet plasma plasma sample plasma samples quantified reflect respiratory SARS-CoV-2 SARS. severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly significantly higher Viral Viral RNA Viremia virion virions virus particle virus particles Visualization vRNA WHO World Health Organization
[DOI] 10.1093/cid/ciab686 PMC 바로가기 [Article Type] Observational Study

SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells

1차 인간 기도 상피 세포에서 SARS-CoV-2 비리온 감염성과 사이토카인 생산

Article

Published on 2022-05-022022-09-11
Journal: Viruses
[Category] COVID19(2023년), SARS, 변종,

[키워드] Activation Alpha B.1.1.529 B.1.1.7 B.1.351 B.1.617.2 BavPat1 Behavior Beta Cell cultures cytokine D614G mutation epithelial epithelial cell epithelial cells Evidence Ex vivo hAEC Human human airway human airway epithelial infect Infectivity Innate immunity isolate lack Lineage lineages new SARS-CoV-2 no difference observé Omicron variant Omicron variants organotypic model Physiology primary human airway Primary human airway epithelial cells Production provide replacement replicate respiratory tissue respiratory tissues SARS-CoV-2 SARS-CoV-2 variants variant variants variants of concern variants of concern. virion virus vRNA
[DOI] 10.3390/v14050951 PMC 바로가기 [Article Type] Article

An overview on inactivated and live-attenuated SARS-CoV-2 vaccines

불활성화 및 약독화 SARS-CoV-2 백신에 대한 개요

Review

Published on 2022-05-012022-09-11
Journal: Journal of Clinical Laboratory Analysis
[Category] COVID19(2023년), SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse effects antigenic attenuated vaccine benefit Bharat Cell culture Cellular immune response China clinical trials component components coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine deaths effective Efficiency Features followed by Health Organization humoral Humoral and cellular immune responses immune responses inactivated Inactivated vaccine Infection landscape Phase 3 produced producing Record report review. Safe SARS-CoV-2 SARS-CoV-2 vaccine severe acute respiratory syndrome Coronavirus similarity Sinopharm Sinovac storage the vaccine Transport trials Vaccine vaccine candidate vaccine platform Vaccines virion virus particle WHO World Health Organization worldwide pandemic Wuhan
[DOI] 10.1002/jcla.24418 PMC 바로가기 [Article Type] Review